Tenor Capital Management’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-200,000
Closed -$496K 415
2023
Q2
$496K Hold
200,000
0.01% 186
2023
Q1
$292K Hold
200,000
0.01% 237
2022
Q4
$388K Hold
200,000
0.01% 329
2022
Q3
$78K Hold
200,000
﹤0.01% 468
2022
Q2
$120K Hold
200,000
﹤0.01% 483
2022
Q1
$176K Hold
200,000
﹤0.01% 508
2021
Q4
$409K Buy
+200,000
New +$305K 0.01% 474

Tenor Capital Management's ROIVW Position: Q3 2023 in Review

Tenor Capital Management sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q3 2023, closing a stake of 200,000 shares — an estimated $496K sold.

Tenor Capital Management first reported a position in ROIVW in Q4 2021 and held it in 7 quarters. The position peaked at $496K in Q2 2023. 0 funds tracked by Wall St. Rank hold ROIVW as of Q3 2023.

  • Tenor Capital Management reported no remaining Roivant Sciences Ltd. Warrant position as of Q3 2023 after selling out during the quarter.
  • Tenor Capital Management sold 200,000 Roivant Sciences Ltd. Warrant shares in Q3 2023, an estimated $496K.
  • Tenor Capital Management first reported a position in Roivant Sciences Ltd. Warrant in Q4 2021 and held it in 7 quarters.
  • Tenor Capital Management's Roivant Sciences Ltd. Warrant position peaked at $496K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q3 2023.

Based on Tenor Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.